You are here

Seven Bridges Selected by DDL Diagnostic Laboratory to Streamline Next-Generation Sequencing Analysis Workflow Development

BOSTON, April 11, 2019 /PRNewswire/ -- Seven Bridges – the industry-leading unified bioinformatics solutions company, today announced that they have been selected by DDL Diagnostic Laboratory to streamline their diagnostic workflows and increase capacity for microbiome and virology analysis pipelines with the Seven Bridges Complete Bioinformatics Ecosystem.

DDL, a state-of-the-art laboratory specializing in molecular diagnostic testing and assay development based in Rijswijk, The Netherlands, has selected Seven Bridges to utilize the platform in conjunction with DDL's current pipeline management tool. By utilizing the Seven Bridges Platform on the back-end of their current software, DDL has created a simpler, integrated data management, reporting, and next-generation sequencing analysis tool that bridges gaps across all departments.

"By migrating our bioinformatics pipeline to the Seven Bridges Platform we are able to substantially improve the capacity of our microbiome and virology analysis pipelines while maintaining GxP compliance. This enables us to offer enhanced custom pipelines and even faster analyses for our customers on a secure and scalable platform," commented Sander Sonius, IT Manager, DDL Diagnostic Laboratory.

"DDL conducted a comprehensive competitive analysis and we are thrilled to have been selected as their partner of choice as they expand their capacity to serve their customer base," said Bruce Press, Chief Revenue Officer, Seven Bridges. "By utilizing the Seven Bridges technology and professional services, combined with the Common Workflow Language framework, DDL has created a unique competitive advantage in the market."

For more information, on how you can get started with Seven Bridges, please visit sevenbridges.com.

About Seven Bridges

Seven Bridges is the industry-leading unified bioinformatics solutions company accelerating precision medicine by enabling the understanding of biomedical data.  Our platform, analytic tools, and services expertise are driving discovery and drug development at the world's leading academic, biotechnology, government, hospitals, and pharmaceutical entities. Through our collaboration with the largest genomics projects, we connect the world's biomedical information to enable the most efficient analysis at scale. To learn more, visit sevenbridges.com or follow us on LinkedIn and Twitter.

About DDL Diagnostic Laboratory

DDL Diagnostic Laboratory is a state-of-the-art laboratory specialized in (molecular) diagnostic testing and diagnostic assay development. DDL performs advanced (molecular) diagnostic testing on behalf of pharmaceutical companies and clinical laboratories, within the complex framework of preclinical studies and Phase II-IV clinical trials. DDL also designs, develops, and validates novel diagnostic assays and NGS analyses (bio-informatics) pipelines which can be tailor-made for specific diagnostic purposes. Currently, DDL serves multiple international pharmaceutical companies, including 10 of the global Top-20. To learn more visit www.ddl.nl or follow us on LinkedIn 

Contact:
Media
Jennifer Perkins
media@sevenbridges.com

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/seven-bridges-selected-by-ddl-diagnostic-laboratory-to-streamline-next-generation-sequencing-analysis-workflow-development-300830759.html

SOURCE Seven Bridges